Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 Black Phoenix Black Phoenix +35.20%
#3 Velvet Velvet +24.01%
#4 Akedo Akedo +19.95%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#6 Fake World Assets Fake World Assets +16.68%
#7 DoubleZero DoubleZero +13.22%
#8 clBTC clBTC +11.84%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.39%
#10 HOME HOME +10.84%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Bioasis Technologies Inc. Bioasis Technologies Inc.

Bioasis Technologies Inc.

BTI
Classement en actions #39944
Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused... Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.
Prix de l'action
$0.00366968
Dernière synchronisation: 2024-07-23
Capitalisation boursière
$291.42K
Changement (1 jour)
-0.81%
Changement (1 an)
0.00%
Pays
US
Échange Bioasis Technologies Inc. (BTI)

Catégorie

Healthcare
Le prix BTI avec la capitalisation boursière de B
Bioasis Technologies Inc. Bioasis Technologies Inc.
BTI
$0.00366968
Capitalisation boursière de Bioasis Technologies Inc.(BTI)
Capitalisation boursière: $291.42K
En August 2026, Bioasis Technologies Inc. a une capitalisation boursière de $291.42K. Cela fait de Bioasis Technologies Inc. la 39944th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Bioasis Technologies Inc. du 2008 au 2026
BTI par rapport au top 5 des plus populaires stocks
Prix pour BTI L’actif B La capitalisation boursière de B Résultats
Bioasis Technologies Inc. Bioasis Technologies Inc.
$68,873.72 $291.42K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +1,876,829,455.54%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$56,250.42 $291.42K
Apple Inc. Apple Inc.
AAPL
$4.467T +1,532,840,809.29%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$52,564.87 $291.42K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +1,432,408,272.84%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$46,592.25 $291.42K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +1,269,652,791.00%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$35,942.56 $291.42K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +979,445,505.37%